N-Acetylation polymorphism in Japanese patients with sarcoidosis

Pharmacogenetics

Volumn 7, Issue 4, 1997, Pages 341-344

  Asada, Midori ^a   Goto, Harumi ^a   Abe, Masako ^a   Tachibana, Teruo ^b   Suzuki, Yasuyo ^a   Suzuki, Tomokazu ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b OSAKA GENERAL MEDICAL CENTER   (Japan)

Author keywords

Arylamine N acetyltransferase; N Acetylation polymorphism; NAT2*14A; Sarcoides

Indexed keywords

AROMATIC AMINE;

ACETYLATION; ACETYLATOR PHENOTYPE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SARCOIDOSIS;

ACETYLATION; ADULT; ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; MALE; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SARCOIDOSIS;

EID: 0030788781     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199708000-00011     Document Type: Article

References (11)

1. Abe M, Suzuki T, Deguchi T. An improved method for genotyping of N-acetyltransferase polymorphism by polymerase chain reaction. Ipn I Human Genet 1993: 38. 163-168.
2. Bell DA, Taylor JA, Butler MA, Stephens EA, Wiest J, Brubaker LH, Lucier GW. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-American. Carcinogenesis 1993: 14. 1689-1692.
3. Evans DAP. Genetic factors in drug therapy. Clinical and molecular pharmacogenetics. Cambridge: Cambridge University Press, 1993.
4. Ishihara M, Ohno S, Ishida T, Mizuki N, Ando H, Naruse T, Ishihara H, Inoko H. Genetic polymorphism of TNFB and HSP70 genes located in the human major histocompatibility complex in sarcoidosis. Tissue antigens 1995: 46. 59-62.
5. Lin HJ, Han C-Y, Lin BK, Hardy S. Ethnic distribution of slow acetylator mutations in the polymorphic N-acelyltransferase (NAT2) gene. Pharmacogenetics 1994: 4. 125-134.
6. Mashimo M, Suzuki T, Abe M, Deguchi. Molecular genotyping of N-acetylation polymorphism to predict phenotype. Hum Genet 1992: 90. 139-143.
7. Nowack C, Goebel KM. Genetic aspects of sarcoidosis: class II histocompatibility antigens and a family study. Arch Intern Med 1987: 147. 481-483.
8. Shibuta K, Nakashima T, Abe M, Mashimo M, Mori M, Ueo H, Akiyoshi T, Sugimachi K, Suzuki T. Molecular genotyping for N-acetylation polymorphism in Japanese patients with colorectal cancer. Cancer 1994: 74. 3108-3112.
9. Tachibana T, Hiraga Y, Kunikane H, Abe S, Ina Y, Yamamoto M, Nagai S, Izumi T, Hayashi S, Shigematsu N, HLA and familial sarcoidosis in Japan. Sarcoidosis Suppl. J 1992: 83-86.
10. Valsis KP, Weber WW, Bell DA, Dupret J-M, Evans DAP, Grant DM, Hein DW Lin HJ, Meyer UA, Relling MV, Sim E, Suzuki T, Yamazoe Y. Nomenclature for N-acetyltransferase. Pharmacogenetics 1995: 5. 1-17.
11. Weber WW, Hein DW. N-acetylation pharmacogenetics. Pharmacol Rev 1985: 37. 25-79.